-
TSHA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Taysha Gene Therapies (TSHA)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 141.64 mm | 141.64 mm | 141.64 mm | 141.64 mm | 141.64 mm | 141.64 mm |
Cash burn (monthly) | 6.22 mm | 408.67 k | 6.64 mm | 7.62 mm | 6.10 mm | 6.77 mm |
Cash used (since last report) | 12.93 mm | 850.00 k | 13.82 mm | 15.85 mm | 12.69 mm | 14.08 mm |
Cash remaining | 128.70 mm | 140.79 mm | 127.82 mm | 125.78 mm | 128.94 mm | 127.56 mm |
Runway (months of cash) | 20.7 | 344.5 | 19.2 | 16.5 | 21.1 | 18.8 |
13F holders | Current |
---|---|
Total holders | 133 |
Opened positions | 28 |
Closed positions | 19 |
Increased positions | 44 |
Reduced positions | 27 |
13F shares | Current |
---|---|
Total value | 288.03 bn |
Total shares | 210.13 mm |
Total puts | 7.80 k |
Total calls | 48.00 k |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
Avoro Capital Advisors | 20.00 mm | $34.60 bn |
MS Morgan Stanley | 17.64 mm | $30.52 bn |
Paul B Manning | 16.47 mm | $31.78 mm |
FMR | 16.37 mm | $28.31 bn |
BlackRock | 13.53 mm | $23.41 bn |
Ra Capital Management | 10.87 mm | $18.81 bn |
Octagon Capital Advisors | 10.45 mm | $18.08 bn |
Venrock Healthcare Capital Partners III | 9.00 mm | $16.83 mm |
Vanguard | 8.91 mm | $15.41 bn |
RTW Investments | 8.67 mm | $15.00 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jan 25 | Kamran Alam | Common Stock | Grant | Acquire A | No | No | 0 | 431,000 | 0.00 | 1,271,937 |
2 Jan 25 | Kamran Alam | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 1.85 | 431,000 | 797.35 k | 431,000 |
2 Jan 25 | Nagendran Sukumar | Common Stock | Grant | Acquire A | No | No | 0 | 324,500 | 0.00 | 1,222,343 |
2 Jan 25 | Nagendran Sukumar | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 1.85 | 324,500 | 600.33 k | 324,500 |
2 Jan 25 | Nolan Sean P. | Common Stock | Grant | Acquire A | No | No | 0 | 892,500 | 0.00 | 2,078,358 |
2 Jan 25 | Nolan Sean P. | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 1.85 | 892,500 | 1.65 mm | 892,500 |
27 Jun 24 | Paul B Manning | Common Stock | Buy | Acquire P | No | No | 2.25 | 1,333,333 | 3.00 mm | 1,333,333 |
29 May 24 | Laura Sepp-Lorenzino | Common Stock | Grant | Acquire A | No | No | 0 | 49,220 | 0.00 | 49,220 |
29 May 24 | Laura Sepp-Lorenzino | Stock Option Common Stock | Grant | Acquire A | No | No | 3.17 | 98,440 | 312.05 k | 98,440 |